AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹14 Cr | ₹7.19 Cr | ₹6.86 Cr | - | - |
What is the latest Contingent Liabilities ratio of AARTI PHARMALABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹7.19 Cr |
| Mar2023 | ₹6.86 Cr |
| Mar2022 | - |
| Mar2021 | - |
How is Contingent Liabilities of AARTI PHARMALABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹14 Cr | 93.53 | |
| Mar2024 | ₹7.19 Cr | 4.78 | |
| Mar2023 | ₹6.86 Cr | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,410.7 Cr | 3.8% | 9.8% | -17.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 3.8% |
9.8% |
-17.8% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses